Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
84 Cards in this Set
- Front
- Back
sources of medications
|
plants, animals, minerals, lab-created synthetic
|
|
pharmacology
|
the study of the properties and effects of drugs and medications on the body
|
|
drugs
|
chemical agents used in the diagnosis, treatment, and prevention of disease
|
|
dose
|
amount of the medication that is given depending on the patient's size and age
|
|
action
|
the therapeutic effect that the medication is expected to have on the body
|
|
indications
|
the therapeutic uses for a particular medication
|
|
contraindications
|
situations in which a medication should not be given because it would not help or may actually harm a patient
|
|
side effects
|
any actions of a medication other than the desired ones
|
|
idiosyncratic reaction
|
one that is a peculiar, unexpected, or individual reaction to a drug
|
|
trade name
|
brand name that a manufacturer gives to a medication; proper noun and is capitalized; i.e. Tylenol
|
|
generic name
|
its orginal chemical name, not capitalized and is usually suggested by the first manufacturer; i.e. nitroglycerin
|
|
USP
|
United States Pharmacopeia; all medications that are licensed for use in the US are listed by their generic names in the USP
|
|
chemical name
|
precise description of the drug's chemical composition and molecular structure
|
|
official name
|
name assigned by the USP; in most cases it is the generic name followed by "USP."
|
|
3 methods of drug classification
|
Body system, Class of agent, Mechanism of action
|
|
Body system classification
|
categorizing by the system affected by that drug; i.e. cardiac drug
|
|
Class of agent
|
tells how it affects the system; i.e. antipyretic (fever reducer)
|
|
Mechanism of action
|
function of a drug or the particular action of a drug on an organism; vasodilator
|
|
Assay
|
analysis of a substance to determine its constituents and the relative proportion of each
|
|
Bioassay
|
the determination of the strength of a drug by comparing its effect on a live animal or an isolated organ preparation with that of a standard preparation
|
|
CNS
|
central nervous system; comprised of the brain and spinal cord
|
|
PNS
|
peripheral nervous system; comprised of all the nervous tissue outside of the CNS. Includes the somatic and autonomic nervous system
|
|
somatic nervous system
|
controls all voluntary or motor functions
|
|
autonomic nervous system
|
controls all involuntary or automatic functions; works without conscious control and regulates functions of the internal organs, glands, and smooth muscle
|
|
divisions of the ANS
|
sympathetic and parasympathetic nervous systems
|
|
sympathetic nervous system
|
responsible for body's response to shock and stress; "fight or flight"; associated with release of adrenaline from the adrenal glands.
|
|
sympathetic responses
|
shunting of blood to vital organs, increase of heart rate and respirations, increased BP, dilation of pupils, reduction of digestive activity
|
|
parasympathetic nervous system
|
relaxes the body; controls automatic functions during nonstressful times; referred to as "rest and relax" division
|
|
parasympathetic responses
|
slowing of heart and respiratory rates, lowering BP, constriction of pupils, increasing digestive activity
|
|
afferent
|
coming towards the brain
|
|
efferent
|
going away from the brain
|
|
adrenergic
|
from adrenals; epinephrine/norepinephrine; sympathetic response
|
|
cholinergic
|
acetylcholine;parasympathetic response
|
|
4 types of adrenergic responses
|
alpha 1 - vasoconstriction
alpha 2 - peripheral vasodilation, little or no bronchoconstriction beta 1 - increased heart rate, automaticity, contractility and conductivity beta 2 - bronchodilation |
|
sympathomimetics
|
mimic the effects of the sympathetic nervous system
|
|
sympatholytics
|
(antiadrenergics) antagonize or fight against the effects of the sympathetic nervous system
|
|
beta blockers
|
work by filling a portion of the beta receptor sites to prevent binding by beta stimulators that occur naturally in the body
|
|
10th cranial nerve
|
vagus nerve where majority of the innervation of the parasympathetic nervous system comes from
|
|
acetylcholine
|
the neurotransmitter for the parasympathetic division; cholinergics
|
|
parasympatholytics
|
antagonists to the parasympathetic nervous system (anticholinergics)
|
|
parasympathomimetics
|
agonists to the parasympathetic nervous system
|
|
pharmacokinetics
|
absorption, distribution, metabolism, and excretion; the movement of the medication through the body; how it enters, where it goes, how it leaves
|
|
pharmacodynamics
|
the study of drugs and their actions on living organisms; drug receptor interaction; how the medication changes the body; its mechanism of action
|
|
4 stages drugs go through
|
absorption, distribution, metabolism, and excretion
|
|
agonist
|
drug that interacts with a receptor to stimulate a response
|
|
antagonist
|
drug that attaches to a receptor site to block a response
|
|
partial agonist
|
drug that interacts with a receptor to stimulate a response but inhibit other responses
|
|
solution
|
liquid mixture of one or more substances that cannot be separated by filtering or allowing the mixture to stand
|
|
suspension
|
substance ground into fine particles that do not dissolve well in liquids
|
|
MDI
|
metered dose inhaler; miniature spray canister used to direct substances through the mouth and into the lungs
|
|
topical medications
|
applied to the surface of the skin
|
|
transdermal medications
|
transcutaneous medications designed to be absorbed through the skin
|
|
gel
|
semiliquid substance administered orally through capsules or plastic tubes
|
|
oral glucose
|
a simple sugar that is readily absorbed by the bloodstream
|
|
inhalation route
|
medications that are aerosolized and drawn into the lungs as the patient breathes
|
|
enteral drugs
|
administered along any portion of the gastrointestinal tract including sublingual, buccal, oral, rectal, and nasogastric routes
|
|
parenteral drugs
|
administered through any route other than the gastrointestinal tract including IV, IM, IO, SC, transdermal, intrathecal, inhalation, intralingual, intradermal, and umbilical injection
|
|
absorption
|
the passage of a substance through some surface of the body into body fluids and tissues
|
|
fastest way to deliver medication
|
IV
|
|
bioavailability
|
rate and extent to which an active drug enters the general circulation, permitting access to the site of action
|
|
osmosis
|
movement of a solvent (fluid) from an area of lower solute concentration to an area of higher solute concentration
|
|
filtration
|
removal of particles from a solution by allowing the liquid portion to pass through a membrane or other partial barrier
|
|
biotransformation
|
the chemical alteration that a substance undergoes in the body
|
|
primary organ for biotransformation
|
liver
|
|
excretion
|
elimination of waste products from the body
|
|
therapeutic effect
|
beneficial action of a drug to correct a body dysfunction
|
|
efficacy
|
the ability to produce a desired effect
|
|
therapeutic threshold
|
minimum concentration required to produce the desired response
|
|
therapeutic index
|
the difference between the minimum effective concentration and a toxic level
|
|
iatrogenic response
|
an adverse condition induced in a patient by the treatment given; UTI after insertion of a foley catheter
|
|
tolerance
|
a progressive decrease in susceptibility to the effects of a drug after repeated doses
|
|
cross-tolerance
|
tolerance to a drug that "bleeds over" to other drugs in the same class
|
|
cumulative effect
|
action of increased intensity after administration of several doses of a drug
|
|
polypharmacy
|
taking several medications each day
|
|
DEA classification of controlled substances
|
Schedule I - no accepted medical use (heroin, etc.)
Schedule II - high abuse and dependence potential (morphine, demerol) Schedule III - moderately high abuse and dependence potential (Tylenol with codeine) Schedule IV - moderate abuse and dependence potential (valium, phenobarbital) Schedule V - low abuse and dependence potential (robitussin A-C) |
|
EMT-I 1985 meds
|
Oxygen, Activated charcoal, Oral glucose, D50W; assist patients with: Epinephrine, nitroglycerin, MDI medications
|
|
adsorption
|
to bind or stick to a surface
|
|
documentation of medication adminstration includes:
|
name of med, dose, route, vital signs before and after
|
|
adrenal glands
|
endocrine glands located on top of the kidneys that release adrenaline when stimulated by the sympathetic nervous system
|
|
buccal
|
medication route between cheek and gums
|
|
half-life
|
time required by body, tissue, or organ to metabolize or inactivate half the amount of substance taken in; important consideration in determining proper dose and frequency of adminstration
|
|
PO
|
per os; through the mouth, oral
|
|
PR
|
per rectum
|
|
sublingual
|
under the tongue
|